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summary
Introduction. The authors analysed the social exclusion of intravenous roma and non-roma drug users who are outside the 
treatment system. The goal of the study was to explore the barriers to treatment of the two groups and to see if the roma group 
had a lower access rate to drug treatment.
Methods. subjects: There were 70 roma and 70 non-roma subjects from clients of needle exchange services and their friends. 
The subjects were recruited by snowball techniques in budapest (capital of hungary). The two group members were selected 
to be similar in terms of their major socio-demographic characteristics. a questionnaire was developed regarding barriers to 
treatment and the need for treatment as well as regarding their drug use and risky behavior.
Results. indicators of social exclusion suggest a less favourable situation for the roma subjects (education, employment, source 
of income, criminality). on the basis of their drug use and high-risk behavior, the roma are not a higher risk group (injecting 
drug use, frequency of drug use, sharing behavior, hepatitis testing, hepatitis c infection, participation in needle exchange ser-
vice). The probability of obtaining treatment can not be explained by ethnic background.
Conclusions. roma drug users are at a greater risk from a social standpoint, while in relation to health and drug behavior, they 
are at a lower risk. The results do not fit in with earlier studies on roma populations with high risk drug using profiles. regard-
ing the study’s results, some limitations can be considered: low number of subjects studied, the special populations from needle 
exchange services.
Key words: injecting drug use, roma health, barriers to treatment, hungary
INTRODUCTION
According to the Council of Europe, there are ap-
proximately 10 million Roma in Europe (estimates vary 
from 8 to 15 million; “approximately 10 million” seems 
to us to be the best estimate). They are mainly found 
in the Balkans and in Central and Eastern Europe (2). 
According to the Council of Europe’s data on the Roma 
population in Hungary, the official number of Roma 
people (according to the 2001 census) is 190,046. The 
estimated numbers are between 400,000 and 800,000 
(2). In Hungary, most of the Roma people do not speak 
a Roma language (3). The total population of Hungary is 
10 million inhabitants.
“The 1993 Hungarian Act on the Rights of Nation-
al and Ethnic Minorities (Minorities Act) clearly made 
ethnic classification the exclusive right of the individ-
ual. Self-identification has thus become the sole legal 
ground for defining ethnicity” (3 p. 14). This is why we 
asked study persons to identify their own ethnicity. We 
also note that “The words Roma (Roma) and cigány 
(Gypsy) are used as synonyms in Hungary, although 
there is no consensus on the correct, un-stigmatised 
name” (3 p. 16).
With regard to the characteristics of Roma groups 
in terms of drug use, we must first note that both the 
international and domestic data are either insufficient 
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or inconsistent. One reason for this is that during the 
course of data collection it is not permitted to ask 
about ethnic origins in the examination of a large, rep-
resentative sample, and on the other hand the exist-
ing research does not completely satisfy numerous 
methodological criteria. In the latter case, we believe 
that it is primarily the lack of a representative sample 
(in many cases, the studies in question are local stud-
ies) and the reliability of the sources of information 
(experts’ estimates) which can significantly influence 
the ability to interpret and make generalizations from 
the data. We are attempting to provide an overview of 
the barriers preventing Roma individuals from obtain-
ing treatment through a review of international (Euro-
pean) and domestic literature.
International studies: Roma drug users  
not undergoing treatment 
The study by Grund, Öfner and Verbraeck (4) states 
that Roma drug users in the central European region 
are less willing to seek out assistance with social or 
healthcare issues, including low-threshold services. 
This increases their marginalized status, while margin-
alization contributes to their unwillingness to seek aid. 
The discrimination and stigmatization of Roma drug us-
ers can also be felt in the treatment facilities, as well as 
in the wider realm of society. The study performed by 
the United Nations Development Programme (5) high-
lights the fact that one of the impediments to obtaining 
basic healthcare and social assistance – in addition to 
geographic distance – is the lack of information, which 
represents a barrier for both Roma drug users and non-
users. 
British and Dutch researchers (6-9) – also basing 
their studies primarily on the opinions of experts – 
examined the factors which keep members of ethnic 
minorities, including Roma drug users, away from the 
various treatment programs available. On the basis 
of these studies, they identified the following factors 
which make it more difficult to receive treatment for 
drug addiction: 
– The lack of cultural sensitivity: the treatment cen-
ters do not take into account the family’s primary 
role in Roma groups, or ignore the opportunity 
to bring family members into the treatment pro-
grams;
– Fearing stigmatization, the Roma users do not dare 
to resort to seeking treatment;
– The differing backgrounds of the treatment workers 
and the users: the non-Roma professionals do not 
show sufficient cultural sensitivity and empathy;
– Mistrust of the treatment centers; 
– Language difficulties. 
During an Irish study in 2005 of itinerant Roma 
groups, (10) identified the following factors which make 
it more difficult for these people to receive healthcare 
treatment: 
– The lack or low degree of knowledge about treat-
ment types; 
– The low level of schooling and education in itiner-
ant Roma groups, and the illiteracy that arises from 
this; 
– Discrimination and stigmatization of the Roma 
in healthcare at the individual and institutional 
levels; 
– The concealment from professionals of problems 
arising from drug use; 
– The lack of treatment programs specific to the cul-
ture and target group; 
– The lack of cultural sensitivity in the relevant institu-
tions. 
Data was collected from primary sources in Bul-
garia (11), providing more information about Roma 
drug users in Sofia. The workers at the Sofia needle 
exchange center identified the lack of healthcare pro-
vision for Roma intravenous drug users as the most 
commonly experienced difficulty (81%). They named 
the low level of education and the state of their health 
as being secondary concerns, and poor living condi-
tions, the closed nature of the Roma community and 
discrimination as further barriers. Research performed 
on a sample from a Spanish treatment center that 
deals with drug users studied the likelihood that Roma 
and non-Roma drug addicts would remain in treatment 
(12). The results showed that remaining in treatment is 
more likely in the case of non-Roma addicts, although 
the result was not statistically significant. An important 
component of the analysis was that a history of treat-
ment has an impact on whether or not users remain 
in treatment, and this impact is significant in the case 
of Roma drug users. The importance of this is that in 
the case of the Roma, the socializing effect of a his-
tory of treatment is significant as regards the success 
of their continuing course of treatment. In conclusion, 
it is worth mentioning Subata’s (1997) (13) research, 
who observed at a methadone maintenance center in 
Vilnius that the Roma drug users did not make use of 
the services, due on the one hand to geographic dis-
tance, and on the other to a lack of trust in the workers 
there. In Spain, due to similar difficulties, the criteria 
for receiving methadone maintenance treatment were 
relaxed (14). 
Hungarian studies: Roma drug users  
not undergoing treatment 
In practice, no focused study has been conducted 
in Hungary that has made a comprehensive attempt to 
uncover the drug use characteristics and patterns of 
the Roma, or to explore the barriers they meet in ob-
taining treatment. Although certain researchers have 
dealt with the topic in a secondary manner (15, 16), 
the only comprehensive and focused study was con-
ducted by Ritter (2005) (17), who – even if only to a 
minor degree – studied the barriers to obtaining treat-
ment. Of the drug users questioned, 4.5% indicated 
that they had taken part in a treatment program for 
their drug problem. This meant primarily in-patient hos-
pital treatment or an out-patient drug clinic. Of these, 
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a total of only two people stated that they underwent 
treatment because they needed it; it was far more typi-
cal that they sought out an aid center due to advice 
or pressure from their immediate environment (family 
members or friends). The researchers did not exam-
ine the possible reasons for such a low percentage of 
Roma drug users who had participated in a treatment 
program. At the same time, it is an interesting fact that 
more than three-quarters of those questioned (76.7%) 
knew a Roma youth who, according to their opinion, 
was in need of treatment, but had not entered into a 
program. They saw the primary reason for this as be-
ing that the person in question did not want to quit, or 
did not feel the need for treatment. 
The limitation of this research was that there was no 
opportunity for a comparison with non-Roma drug us-
ers in terms of either the frequency of drug use or en-
rollment in treatment programs, or in connection with 
the reasons for the barriers and difficulties in obtaining 
treatment. 
From the synopsis above of the literature, it is there-
fore easy to see that numerous factors influence the 
entrance into, the need for and the seeking out of treat-
ment by problematic drug users, including users of 
intravenous drugs. The research and studies outlined 
above suggest that numerous factors are not specific 
to culture or background; they may be found equally in 
groups of both Roma and non-Roma intravenous drug 
users. At the same time, we repeatedly met with expla-
nations relating to discrimination due to the subjects’ 
Roma ethnic origins and the shortage of information, as 
well as factors arising from the Roma culture and way of 
life, such as the closed nature of the Roma community 
and the differing attitudes of the Roma to their health 
and physical condition. 
There are several methodological problems with 
Roma drug users, it is also a problem that who many 
are in treatment and what the main barriers are to get 
treatment. A speacial geographical region (the 8th 
district of Budapest) was chosen, wher Roma snd 
non- Roma drug users live together. Here a needle ex-
change program is run so we can study the clients of 
this program.
The objectives of the research were to:
– Explore the characteristics of socially excluded (and 
at the same time those not undergoing treatment) 
intravenous drug users, as regards their drug use, 
and furthermore the types of service they obtain (or 
do not obtain);
– Discover what knowledge Roma and non-Roma 
intravenous drug users have about the various 
treatment programs, identify their reasons for not 
entering into treatment and uncover their relation-
ship with and attitudes towards the treatment sys-
tem;
– Explore the differences in drug use patterns be-
tween Roma and non-Roma users, and the high-
risk or preventative behaviors related to their drug 
use;
– Identify the characteristics of the intravenous drug 
users who classify themselves as Roma and non-
Roma, assuming that the drug users who classify 
themselves as Roma do not represent a homog-
enous group. 
METHODS
Sample
Intravenous drug users can be considered as a hid-
den target population, with whom the traditional random 
sampling and data acquisition procedures cannot be em-
ployed, or can only be employed in a limited fashion (24). 
The study was carried out in the capital (Budapest: 
2 million inhabitans), in the 8th district of Budapest 
(82.000 inhabitans). Here, the Blue Point Drug Counsel-
ling and Outpatient Centre runs a needle exhange ser-
vice. The clients of this service were the points of snow-
ball samples of the study groups.
During the course of the research, 70 Roma intrave-
nous drug users who were not in treatment programs 
were questioned, as well as a further 70 non-Roma as a 
comparison group (total: 140 persons). For the purpose 
of comparability, the major socio-demographic and 
drug use characteristics of the group being examined 
and the control group were similar. The formation of the 
comparison sample occurred continuously during the 
course of the data collection process, at the same time 
as the Roma sampling, using a so-called quota sample. 
This method of sampling required the continuous reg-
istration of quotas based on major socio-demographic 
characteristics, and the continuous supervision of the 
data collection process (12).
Data collection
During the course of the research, in addition to the 
utilization of questions that could be adapted from in-
ternational surveys (regarding the socio-demographic 
background, treatment history, health and social status, 
drug use habits, perception of risks relating to infection 
and barriers to obtaining treatment of the drug users), 
there were also operationalization questions regarding 
the attitudes of the intravenous drug users towards the 
people providing the services. 
The assessment methods that we took into account 
during the development of the questionnaire and that 
we wanted to use in order to measure the barriers to ob-
taining healthcare and social welfare treatment, as well 
as for measuring social exclusion, were adapted from 
the following: 
1. The barriers to obtaining treatment for intravenous 
drug users on the street in New York (18);
2.  Barriers to obtaining treatment for illegal drug users 
in Australia (19);
3.  The need for medical and psychosocial treatment 
amongst intravenous drug users in a treatment sam-
ple (20);
4.  The previously validated Hungarian version of the 
questionnaire examining the habits of intravenous 
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drug users developed by the National Institute on 
Drug Abuse (NIDA) (21);
5.  A questionnaire which we produced ourselves that 
was utilized during the course of research performed 
amongst problematic drug users in Budapest who 
were not in treatment programs (22);
The Heroin Severity Dependence Scale that has 
been used in international research and has also 
been validated in Hungary was included in the ques-
tionnaire (21, 23).
Following a period of instruction regarding the pre-
prepared, partially structured interviews, they were con-
ducted in the street by social workers participating in 
the research and who were employed by low-threshold 
service providers. 
PROCEDURE
The data sampling occurred between December 
2007 and March 2008.
During the course of the study, we creat a sample 
of 70 non-Roma drug users who were not undergo-
ing treatment to the snowball sample consisting of 70 
Roma (total: 140 persons). During this alignment pro-
cess, we took into account two considerations in addi-
tion to the appropriate drug use history: the sex and age 
of the subjects. The configuration of the two samples 
occurred continuously, with the basis being the Roma 
sample, and the interviewers had to constantly align the 
“non-Roma” sub-sample in order to agree with the other 
group. We determined that the difference in age could 
be +/- two years. During the snowball sampling of the 
“Roma” sample, our objective was for the questioning 
to be initiated from as many points as possible, and that 
the chain should be as long as possible. The drug users 
received a 1,000 Hungarian Forint shopping voucher in 
exchange for taking part in the interview.
We entered the interview data into the Statistical 
Package for the Social Sciences (SPSS) database, and 
the processing of the data also occurred with the help of 
this statistical software package. 
Considerations for research ethics 
The Scientific Research Ethics Board of the Hungar-
ian Academy of Sciences’ Psychological Research Insti-
tute issued the required ethics permit for the research. 
We also consulted the Office of the Parliamentary Com-
missioner for Data Protection. 
RESULTS
Univariate analysis methods
Socio-demographic indicators 
The majority of the drug users in the samples were 
male, 18-35 years old and single but living with some-
Table 1. The presentation of the sample according to socio-demographic characteristics.
Non-Roma drug users Roma drug users Full sample
Sex 
Male  67.1  80.0  73.6 
Female  32.9  20.0  26.4 
Age group   
18-25 years old  28.6  37.1  32.9 
26-30 years old  32.9  38.6  35.7 
31-35 years old  21.4  14.3  17.9 
36 years old or above  17.1  10.0  13.6 
Size of household    
1 person  14.3  7.1  10.7 
2 people  28.6  17.1  22.9 
3 people  24.3  27.1  25.7 
4 people  20.0  21.4  20.7 
5 people or more  12.9  27.1  20.0 
Number of children in the household    
No children  71.4*  50.0*  60.7 
1 child  18.6*  27.1*  22.9 
2 or more children  10.0*  22.9*  16.4 
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Non-Roma drug users Roma drug users Full sample
Marital status    
Single  57.1  48.6  52.9 
Married  7.1  8.6  7.9 
Cohabiting  25.7*  37.1*  31.4 
Divorced  7.1  5.7  6.4 
Widow/widower  2.9  1.4 
Who are you living with?    
No-one/alone  12.9  10.0  11.4 
Spouse  2.9  11.4  7.1 
Partner  30.0  30.0  30.0 
Parent(s)  48.6  44.3  46.4 
Friends  8.6  5.7  7.1 
A child under 18 years of age  14.3  35.7  25.0 
Other family  24.3  25.7  25.0 
Other adults  2.9  10.0  6.4 
Level of education    
Lower than 8th grade  7.1  20.0  13.6 
8th grade  20.0  38.6  29.3 
Incomplete vocational secondary school education  17.1  22.9  20.0 
Incomplete high school education  5.7  1.4  3.6 
Vocational secondary school diploma  28.6  14.3  21.4 
High school diploma  12.9  6.4 
National Instruction Registry training  4.3  2.9  3.6 
Incomplete college or university education  2.9  1.4 
College or university diploma  1.4  0.7 
Living conditions    
Self-owned residence  17.1  15.7  16.4 
Other residence  42.9  32.9  37.9 
Tennant  11.4  12.9  12.1 
Homeless shelter  1.4  0.7 
Street  4.3  2.9  3.6 
Squat  8.6  2.9  5.7 
Municipal housing  11.4  32.9  22.1 
Other  1.4  0.7 
No response  1.4  0.7 
*p < 0.05
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one. Most people in the sample did not complete either 
elementary or secondary school. The number of home-
less people was insignificant. The proportion of those 
raising a child/children was relatively high (39%). No-
where did a significant difference develop between the 
two sub-groups in terms of their socio-demographic 
data.
Drug use characteristics 
On the basis of a survey of the life prevalence values 
of particular illegal drugs, we can see that the value for 
amphetamines is the highest in both sub-samples, and 
this is followed by marihuana. Significant differences be-
tween the Roma and the non-Roma participants can be 
observed in two areas: in the case of non-prescribed 
methadone (purchased on the street), and for hypnotics 
and sedatives. 
As regards the participants’ drug use in the past 
30 days, we can see that the use of amphetamine de-
rivatives was the most common practice, particularly 
amongst Roma drug users, amongst whom the propor-
tion who had used these kinds of drugs was 83%. Over 
half of the sample also used marihuana on a regular 
basis, and nearly a third of the sample took sedatives 
and hypnotics not in accordance with doctor’s recom-
mendations. The use of amphetamines and ecstasy was 
more typical of the Roma population, while the use of 
heroin as well as hypnotics and sedatives was charac-
teristic of the non-Roma population. 
With regard to initial use, we observed that in the cas-
es of both the Roma and non-Roma drug users, the ini-
tial regular use of marihuana occurred earliest, while the 
use of non-prescribed methadone occurred last. There 
was no significant difference between the two sub-sam-
ples for any drug. 
On the basis of the international scale for measur-
ing drug dependence (fig. 1), in which the larger values 
indicate greater levels of dependence, all of those ques-
tioned received a score between four and 16. The entire 
sample studied had an average dependence value of 
9.52, which includes an average value of 10.2 for the 
Roma sample and 8.8 for the non-Roma sample. The 
difference between the two samples proved to be sig-
nificant (t = 3.8; p<0.001). 
Forms of high-risk behavior 
Although the incidence rate of the sharing of needles 
in the last 30 days was low for the total sample, as well 
as for both the Roma and non-Roma populations, the 
values for the other forms of risky behavior were high. 
Amongst the differences examined, there was a signifi-
cant disparity between the Roma and non-Roma popu-
lations relating to the incidence of sharing paraphernalia 
in the last 30 days. 
Table 2. Prevalence values for illegal and legal drugs (lifetime prevalence, %).
 Non-Roma drug users Roma drug users Full sample
 Injecting heroin 64.3 62.9 63.6
 Injecting amphetamines 97.1 95.7 96.4
 Non-prescribed methadone 37.1* 23.2* 30.2
 Marijuana 88.6 928 90.6
 Ecstasy 74.3 79.7 77.0
 Hypnotics and sedatives 62.9* 42.0* 52.5
*p < 0.01
Table 3. Drug use in the last 30 days (%).
 Non-Roma drug users Roma drug users Full sample
Injecting heroin 57.1* 40.0* 48.6
Injecting amphetamines 61.4* 82.9* 72.1
Non-prescribed methadone 17.1 5.7 11.4
Marihuana 51.4 54.3 52.9
Ecstasy 12.9* 21.4* 17.1
Hypnotics and sedatives 40.0* 24.3* 32.1
*p < 0.01
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Infections and participation in screening 
In connection with inquiries about HIV and hepa-
titis, it can be stated that there was a disparity be-
tween the Roma and the non-Roma as regards their 
participation in screening, but that this difference was 
not significant. While 80.0% of the Roma had been 
screened for HIV, 71.4% of the non-Roma had, and 
84.3% of the Roma and 73.0% of the non-Roma had 
been screened for hepatitis at some point in their 
lives. 
Only one individual in the sample was found to be 
HIV positive. In contrast with the rate of HIV infection, 
one-fifth of the total sample was positive for hepatitis, 
while 39.9% of them thought they were not. While the 
Roma and the non-Roma had an HCV infection rate of 
27.1% and 11.4%, (on the basis of the screening results; 
p<0.05), the proportion of those who were not infected 
was nearly the same for the Roma (38.6%) and the non-
Roma (40.0%) on the basis of their own admission. It is 
an interesting fact that one-fifth of the sample could not 
say, or did not respond to the question (Roma: 18.6%; 
non-Roma: 21.4%), and that 21.4% of the entire sample 
had not been screened for hepatitis. With regard to hep-
atitis, 27.1% of the non-Roma and 15.7% of the Roma 
had not been tested. These disparities were statistically 
significant, although barely so (10.71; p<0.05). 
THE RELATIONSHIP WITH THE TREATMENT SYSTEM 
FOR DRUG USERS WHO WERE NOT UNDERGOING 
TREATMENT 
Participation in low-threshold services (needle 
exchange) 
The data relating to needle exchanges shows that a 
significant portion of those in the sample (92.8%) had 
utilized these kinds of services in some form during their 
lives. Amongst the Roma, this was true of everyone, 
and 85.7% of the non-Roma admitted to using needle 
exchanges. This disparity is significant. Of the entire 
sample, 84.3% had participated in needle exchanges in 
the last 30 days. This included an overwhelming major-
ity of the Roma (94.3%), and three-quarters (74.3%) of 
the non-Roma (18.65; p<0.001).
Treatment history
Taking into account the participants’ treatment histo-
ries, we can see that 20% of the sample had been in one 
of the types of treatment studied during the course of 
this research, with the proportion being slightly higher for 
the Roma drug users than the non-Roma, although this 
disparity was not significant. Amongst those with a his-
tory of treatment, the majority (n=25) had participated in 
only one form of treatment, and only three respondents 
had participated in two different forms of treatment. 
Attempts and experiences relating to obtaining 
treatment
We also explored any unsuccessful attempts 
at enrolling in programs in relation to the subjects’ 
history of obtaining treatment. Of the entire sample, 
19% (27 individuals) had attempted to enroll in some 
kind of treatment program, but were not successful. 
There was a significant disparity between the two 
sub-samples as regards these unsuccessful attempts 
(p<0.05). In the case of the Roma drug users, the per-
centage who did not receive treatment despite trying 
to enroll was 24%, while for the non-Roma drug users 
this was 14%. 
Unsuccessful attempts at enrolling in methadone 
treatment were the most common, while smaller propor-
tions of the participants had made unsuccessful attempts 
at obtaining out-patient or hospital in-patient care. The 
reasons given for failing to gain admittance were most 
Fig. 1. Severity dependence scale (min: 4, max: 16).
Table 4. Incidence of forms of high-risk behavior at any time and in the last 30 days (%).
 Non-Roma drug users Roma drug users Full sample
Sharing of needles at any time 60.0 51.4 55.7
Sharing of needles in the last 30 days 7.1 11.4 9.3
Sharing of paraphernalia (filters, strainers etc.) at any time 70.0 80.0 75.0
Sharing of paraphernalia (filters, strainers etc.) in the last 30 days 44.3* 60.0* 52.1
*p < 0.01
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often a lack of space, or in other words they were put on 
the waiting list but did not obtain the services. 
Multivariate analysis methods
In connection with assessing the participants’ treat-
ment histories or what treatment they had obtained, we 
performed a logistic regression where we entered the 
variables that showed deviation into a single-variable 
statistical proof. These variables were: age; sex; level 
of education; ethnic background (Roma/non-Roma); 
drug addiction (on the basis of the Severity Depen-
dence Scale); the length of drug use and whether the 
participants had drug users who had received treat-
ment amongst their friends and family members (yes 
or no). 
On the basis of the analysis of the logistic regression, 
we can state that amongst the numerous factors that 
we examined, only the level of drug dependence had 
an independently significant impact on the participants’ 
treatment histories, or in other words, the chance of en-
tering into treatment increased with an increase in drug 
dependence (OR = 0.41; p<0.001). 
Assessment of treatment obtained
We assessed the drug users who were not undergo-
ing treatment with the aid of a five-tiered scale, as to how 
difficult or easy they considered it to enroll in particular 
types of treatment programs. In connection with assess-
ing the difficulty of enrolling in treatment programs, we 
can see that both sub-samples considered obtaining 
methadone treatment to be the most difficult, while out-
patient treatment proved to be the easiest to receive, al-
though hospital in-patient treatment had a similar value. 
No significant disparity developed between the two sub-
samples. 
In connection with admittance to the particular treat-
ment centers, we also examined which factors influ-
enced the assessment process, or, in other words, we 
examined the background factors which the drug us-
ers thought made it harder to enter certain treatment 
centers. We performed this examination using a multi-
variable linear regression analysis. We examined the 
four different types of treatment separately, utilizing the 
same independent variables in each case. The depen-
dent variables employed during the analysis were the 
assessment of admittance to the particular types of 
treatment (on a scale of 1-5).
The independent variables employed during the 
analysis were: sex; age; ethnicity; length of drug use; 
level of drug dependence; treatment history and num-
ber of attempts to enroll for treatment. 
We found that amongst the background factors 
which we included, the level of drug dependence and 
the history of treatment within the family both had an 
independent impact on the assessment of admittance 
to methadone treatment. This means that the more de-
pendent the drug users were, the more difficult they 
considered it to be to enroll in a methadone program 
(R = 0.18; p<0.001). Furthermore, the drug users who 
did not have any drug users who had previously re-
ceived treatment in their family considered admittance 
into treatment to be more difficult (R = 0.9; p<0.001). 
The other independent variables did not have any sig-
nificant individual impact.
Regarding the assessment of out-patient treatment, 
the results indicated that, amongst the background fac-
tors which we included, the treatment history of those 
questioned and their family members had an impact. 
Therefore, we can state that if the individuals questioned 
had themselves been in some form of treatment, then 
they considered the chance of receiving out-patient 
treatment to be more likely (R = 0.76; p<0.05). In con-
trast to this, if the individuals questioned had a fam-
ily member who had received some form of treatment, 
then they considered admittance to be more difficult 
(R = 0.76; p<0.05).
The other independent variables did not play a sig-
nificant role in how difficult it was considered to be to 
obtain out-patient treatment.
In terms of the assessment of rehabilitation treatment, 
the results indicated that, amongst the independent fac-
tors included in the analysis, the only one with a signifi-
cant individual impact was Roma ethnicity. According to 
this research, the Roma drug users considered admit-
tance to be more easily obtained than the non-Roma 
drug users did (R = 0.79; p<0.05). 
In connection with the assessment of hospital in-pa-
tient treatment, we saw that only the variable relating to 
drug dependence had an independent impact. In other 
words, those questioned who had a greater level of de-
pendence on drugs considered it to be easier to obtain 
hospital in-patient treatment (R = 0.1; p<0.05). 
DISCUSSION
On the basis of the results of this research, we were 
provided with a relatively diverse picture of Roma and 
non-Roma drug users who were not undergoing treat-
ment. In the various dimensions of the study, we ob-
Table 5. Assessment of the difficulty of enrolling in particular types of treatment programs.
 Methadone treatment Out-patient treatment Rehabilitation Hospital in-patient treatment
Non-Roma drug users 3.60 2.47 3.16 2.58
Roma drug users 3.49 2.51 2.68 2.43
Full sample 3.54 2.49 2.92 2.51
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served that while there was a fairly significant disparity 
between the two groups regarding certain questions, 
they had very similar characteristics in other aspects. 
This also meant that neither the Roma drug users nor 
the non-Roma drug users constituted in themselves a 
homogenous group. 
During this research, a study was performed on 
70 Roma and 70 non-Roma subjects who were not un-
dergoing treatment, but were clients of two low-threshold 
needle exchange programs in Budapest. As well as the 
fact that the subjects were not undergoing treatment, it 
was important that the sample also included those who 
had never been in any kind of treatment program (this 
was true in the majority of cases), and also those who 
had at least a three year history of regular drug use, as 
the healthcare and social problems that would indicate 
the need for treatment would be most likely to arise in 
this period of time. 
The indicators of social exclusion suggested a less 
favorable situation for the Roma drug users, as on aver-
age they had a lower level of education, had less favor-
able indicators as regards employment status, were in a 
somewhat more uncertain situation regarding the sourc-
es of income and were more likely to have a criminal re-
cord. All of these show a great similarity to the results of 
earlier research on itinerant Roma groups performed by 
Fountain (10). It seems that the Roma who were part of 
the sample also bear the marks of social exclusion that 
are characteristic of a significant portion of Hungarian 
Roma groups (25). 
On the basis of other characteristics of drug use, 
forms of high-risk behavior and health characteristics, 
we can state that the Roma drug users cannot be con-
sidered to be at a higher risk as a group in terms of 
their frequency of drug use, drug use history or sharing 
of needles. Moreover, it can be established regarding 
their state of health and certain health-related behav-
iors that there is not a significant difference between 
the Roma and non-Roma people. This relates on the 
one hand to chronic illnesses, or those which occur 
due to drug use, as well as permanent damage to their 
health, and on the other hand to their participation in 
screening programs. A greater percentage of Roma 
drug users had taken part in the various screening pro-
grams, particularly in the last one to two years, and 
took advantage of the needle exchange service to a 
significantly greater degree, typically at the participat-
ing local organization. 
In addition to all of this, it is important to mention 
that ethnic background did not have an impact in con-
nection with the probability of obtaining treatment, or, 
in other words, Roma ethnicity did not make it more 
probable that someone would not receive treatment. 
As was observed, it was only the level of drug depen-
dence that had a significant independent impact in 
relation to treatment history. This result is even more 
interesting in light of the fact that the Roma were more 
likely to attempt to obtain treatment, even if they were 
unsuccessful. In connection with this, during the course 
of our earlier research performed in Budapest amongst 
intravenous drug users who were not receiving treat-
ment (22), we observed that two factors influenced 
whether or not treatment was obtained to a significant 
degree: the length of the subject’s history of drug use, 
and their level of education. Those with a longer his-
tory of drug use and with a higher level of education 
were more likely to enter into some kind of treatment. 
However, during the course of the present research, 
this connection could not be established. Only ethnic 
origin had an independent impact on the assessment 
of rehabilitation treatment; the Roma drug users con-
sidered enrollment to be easier than the non-Roma 
drug users. Our primary hypothesis in connection with 
this is that it could be that the Roma intravenous drug 
users were unfamiliar, or were less familiar, with this 
form of treatment, a fact which has been highlighted in 
other research relating to Roma drug users being less 
well informed (5, 10). At the same time, it may also be 
postulated that the intravenous use of amphetamines 
(which is more characteristic of the Roma) does not 
produce a need for that kind of treatment, or the conse-
quences which would require rehabilitation treatment. 
This would explain why their knowledge of this form of 
treatment is lacking, because the Roma people do not 
know about it, even indirectly. 
At the same time, there was no difference between 
the Roma and non-Roma in connection with their opin-
ions about obtaining hospital, out-patient or methadone 
maintenance treatment. The first two are uniformly con-
sidered to be moderately difficult, regardless of the sub-
ject’s ethnic background, while obtaining methadone 
treatment was judged to be difficult. All of this seems 
to underscore that prejudice against the Roma did not 
factor in amongst the reasons stated either for being 
unsuccessful in entering treatment or for not seeking it 
out.
Therefore, some of the results from this research do 
not support certain results and hypotheses from ear-
lier research. The conclusion reached by Grund, Öfner 
and Verbraeck (4), who stated that Roma drug users 
are not as willing to seek out social or healthcare assis-
tance, can be refuted, including for low-threshold ser-
vices. Discrimination or stigma could not be observed 
in connection with the Roma intravenous drug users 
who took part in the research, at least in terms of their 
chances of being admitted for treatment, as well as in 
their assessment of unsuccessful attempts at obtaining 
treatment or enrollment in the various forms of treat-
ment. This is in contrast with the results of other re-
search (6-10). 
The lack of cultural sensitivity towards the Roma by 
organizations (10) may be called into question by our 
research results, according to which participation in 
screening and needle exchanges is more characteristic 
of Roma drug users than others. Furthermore, a greater 
proportion of Roma than non-Roma drug users take part 
in street needle exchange programs, which are still un-
derdeveloped in Hungary. 
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Regarding the situation in Hungary in terms of 
groups of intravenous drug users, we must also greet 
with skepticism the conclusion of Grund, Öfner and 
Verbraeck (4), according to whom Roma drug users 
represent a special group within drug users: they start 
their drug use earlier and exhibit more high-risk behav-
iors, the result of which is that they have a higher occur-
rence of various infectious diseases (HIV and hepatitis 
B and C). It seems that this conclusion was perfunc-
tory, or that it at least bore the limitation that it was for 
the most part based on consultations with experts and 
chief spokespeople. 
Our study indicated that the use of amphetamines 
and ecstasy is more typical in the Roma population, 
while the use of heroin, hypnotics and sedatives are 
characteristic of non-Roma intravenous drug users. 
Taking into account that the risk of overdosing is more 
likely in the case of sedatives, the non-Roma intrave-
nous drug users in the sample are potentially at greater 
risk. 
Nor can the Roma intravenous drug users in the 
sample be characterized as a homogenous group, as 
Ritter (17) had previously suggested, which was another 
factor used by Grund, Öfner and Verbraeck (4) in their 
determination of homogeneity. 
CONCLUSIONS
In relation to the marginalization of Roma and non-
Roma intravenous drug users from Budapest who are 
not undergoing treatment, the results of this research 
in its entirety indicate that Roma drug users seem to 
be at higher risk from a social perspective, while in 
connection with health issues linked to drug use their 
level of exclusion is no so significant or in certain re-
spects not excluded at all. In order to answer all of 
these questions in more depth, more precise research 
is needed. 
LIMITATIONS 
One limitation of this research was that the study only 
extended to intravenous drug users from Budapest who 
were not receiving treatment, but they participated in nee-
dle exchange services. Second, during the sampling pro-
cess, we did not have the opportunity to take into account 
all of the districts of Budapest (e.g. Újpest and Csepel) 
where intravenous drug use is also present. It was primar-
ily drug users who were contacted by workers at the Kék 
Pont Drug Clinic or the Drug Prevention Foundation that 
became part of the sample. In order to counterbalance 
this, we employed sampling methods which helped to 
reduce or minimize the aberrations arising from the data 
acquisition during the research process. 
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